Philip Wilkinson
BMedSci BM BS (Nottingham), FRCPsych, Dip Obst (Auckland, New Zealand), Certificate in Cognitive Therapy (Oxford), ATCL, LGSMD, CELTA
Honorary Senior Clinical Lecturer
- Consultant Psychiatrist, Oxford Health NHS Foundation Trust
- Associate Fellow, Green Templeton College, Oxford
I am a consultant old age psychiatrist with Oxford Health NHS Foundation Trust. My interests are the management of late-life depression and psychological treatments with older people.
I am currently a co-investigator and PI with the CONTACT-GAD study of acceptance and commitment therapy for treatment-resistant depression in older people and the ANTLER75+ study of antidepressant continuation in late-life depression. I was co-investigator with the PATHFINDER study of adapted problem-solving therapy for depression in dementia
I was a member of the 2022 NICE Depression in adults (update) guideline development group.
I teach medical students at the University of Oxford and am a College Adviser and Associate Fellow of Green Templeton College. I am also a trained teacher of English to speakers of other languages with an interest in teaching medical English to refugee doctors.
Recent publications
-
Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trial.
Journal article
Howard R. et al, (2024), Alzheimers Dement
-
Acceptance and commitment therapy for older people with treatment-resistant generalised anxiety disorder: the FACTOID feasibility study.
Journal article
Gould RL. et al, (2021), Health Technol Assess, 25, 1 - 150
-
Negative bias in interpretation and facial expression recognition in late life depression: A case control study.
Journal article
Baruch N. et al, (2021), Int J Geriatr Psychiatry
-
Acceptance and commitment therapy for late-life treatment-resistant generalised anxiety disorder: a feasibility study.
Journal article
Gould RL. et al, (2021), Age Ageing
-
18FDG PET-CT in sporadic Creutzfeldt-Jakob disease, correlated with MRI and histology.
Journal article
Morley NCD. et al, (2021), World J Nucl Med, 20, 411 - 413
